Effects of aprepitant on post-operative nausea and vomiting in patients with congenital heart disease undergoing cardiac surgery or catheterization procedures: a retrospective study with subjects as their own historical control

Effects of aprepitant on post-operative nausea and vomiting in patients with congenital heart disease undergoing cardiac surgery or catheterization procedures: a retrospective study with subjects as their own historical control

IntroductionFor patients undergoing cardiac surgery and catheterization procedures, severe post-operative nausea and vomiting (PONV) can occur despite standard anti-emetic interventions. Aprepitant, a neurokinin-1 (NK-1) receptor blocker, is safe and effective at preventing PONV resistant to standar...

Full description

Bibliographic Details
Main Authors:	John W. Belk, Mark D. Twite, Katherine S. Klockau, Lori J. Silveira, Rachel G. Clopton
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Anesthesiology
Subjects:	PONV (postoperative nausea and vomiting) aprepitant congenital heart disease cardiac catheterization congenital cardiac surgery congenital cardiac anesthesia
Online Access:	https://www.frontiersin.org/articles/10.3389/fanes.2023.1190383/full

Similar Items

Aprepitant to control nausea and vomiting in the Pediatric ICU setting
by: R. Manimalethu, et al.
Published: (2019-01-01)

Incidence of Nausea and Vomiting After Fast-Track Anaesthesia for Heart Surgery
by: Emad Mohamed Hijazi, et al.

The efficacy of combination of ondansetron and aprepitant on preventing the radiotherapy-induced nausea and vomiting
by: Hamid Emami, et al.
Published: (2015-01-01)

Assessing the impact of aprepitant and ondansetron on postoperative nausea and vomiting in orthognathic surgeries: a randomized controlled trial
by: Mostafa Alam, et al.
Published: (2023-12-01)

Aprepitant versus ondansetron in preoperative triple-therapy treatment of nausea and vomiting in neurosurgery patients: study protocol for a randomized controlled trial
by: Bergese Sergio, et al.
Published: (2012-08-01)

Efficacy of the oral neurokinin-1 receptor antagonist aprepitant administered with ondansetron for the prevention of postoperative nausea and vomiting
by: Chae Seong Lim, et al.
Published: (2013-03-01)

THE EFFICACY OF APREPITANT (NK-1 RECEPTOR ANTAGONIST) AS PROPHYLAXIS FOR POSTOPERATIVE NAUSEA AND VOMITING
by: Muhammad Akram, et al.
Published: (2020-04-01)

Aprepitant plus palonosetron for the prevention of postoperative nausea and vomiting after breast cancer surgery: a double blind, randomized trial
by: Thiago Ramos Grigio, et al.
Published: (2020-09-01)

Cost-Effectiveness of Aprepitant in Preventing Chemotherapy-Induced Nausea and Vomiting: A Systematic Review of Published Articles
by: Tingting Qiu, et al.
Published: (2021-08-01)

Chemotherapy-Induced Nausea and Vomiting: The Role of Aprepitant
by: Muath Mohammed Abu Hilal
Published: (2011-01-01)

The use of aprepitant in the first cycle of moderately emetogenic chemotherapy in patients with colorectal cancer: its preventive effect on chemotherapy-induced nausea and vomiting
by: Jung Won Ryu, et al.
Published: (2013-06-01)

Perioperative Administration of Emend® (Aprepitant) at a Tertiary Care Children’s Hospital: A 12-Month Survey
by: Kanaparthi A, et al.
Published: (2019-11-01)

The effect of aprepitant for the prevention of postoperative nausea and vomiting in patients undergoing gynecologic surgery with intravenous patient controlled analgesia using fentanyl: aprepitant plus ramosetron vs ramosetron alone
by: Se-Jin Lee, et al.
Published: (2012-09-01)

Association between intraoperative hypotension and postoperative nausea and vomiting: a retrospective analysis of 247 thyroidectomy cases
by: Hitomi Nakatani, et al.
Published: (2023-09-01)

Evaluating Aprepitant single-dose plus granisetron and dexamethasone in children receiving highly emetogenic chemotherapy for the prevention of chemotherapy-induced nausea and vomiting: A triple-blinded randomized clinical trial
by: Aziz Eghbali, et al.
Published: (2023-07-01)

Ondansetron Versus Metoclopramide in Prophylaxis of Nausea and Vomiting for Laparoscopic Cholecystectomy: A Prospective Double-blind Randomized Study
by: Trichak Sandhu, et al.
Published: (2008-04-01)

Enhanced efficacy of aprepitant-based triple prophylaxis in preventing postoperative nausea and vomiting following metabolic bariatric surgery: a single-center, retrospective cohort study
by: Xiaodong Shan, et al.
Published: (2025-02-01)

Association of postoperative nausea/vomiting and pain with breastfeeding success
by: Ramon Abola, et al.
Published: (2017-11-01)

High Dose but not Low Dose Granisetron Decreases Incidence and Severity of Post Anesthesia Shivering (PAS) and Postoperative Nausea and Vomiting (PONV) following Lower Abdominal Surgeries under Spinal Anesthesia
by: Abbasali Dehghani, et al.
Published: (2017-04-01)

Application of Cold Drink in Post Operation Nausea and Vomiting (PONV) Appendectomy Cases in Lubuklinggau
by: Jhon Feri, et al.
Published: (2023-01-01)

Combination Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients with NSCLC Receiving Carboplatin-Based Chemotherapy
by: Shimokawa M, et al.
Published: (2022-09-01)

A comparative study between palonosetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy
by: Dhurjoti Prosad Bhattacharjee, et al.
Published: (2010-01-01)

Addition of 3-day aprepitant to ondansetron and dexamethasone for prophylaxis of chemotherapy-induced nausea and vomiting among patients with diffuse large B cell lymphoma receiving 5-day cisplatin-based chemotherapy
by: Raafat Abdel-Malek, et al.
Published: (2017-09-01)

Comparison of aprepitant versus ondansetron for prevention of postoperative nausea and vomiting: A systematic review and meta-analysis with trial sequential analysis
by: Madhusudan P. Singh, et al.
Published: (2024-09-01)

The Prevalence of Postoperative Nausea and Vomiting in Orthopedic Patients in Imam Khomeini Hospital Complex during 2018-2019: A Cross-Sectional Study
by: Amirhossein Orandi, et al.
Published: (2023-08-01)

Penehyclidine mitigates postoperative nausea and vomiting and intraoperative oculocardiac reflex in patients undergoing strabismus surgery: a prospective, randomized, double-blind comparison
by: Jiacheng Sun, et al.
Published: (2021-02-01)

NK1 receptor antagonists versus other antiemetics in the prevention of postoperative nausea and vomiting following laparoscopic surgical procedures: a systematic review and meta-analysis
by: John Cavaye, et al.
Published: (2022-01-01)

Evaluation and Comparison of Two Different Combined Regimens for Prophylaxis of Nausea and Vomiting After Laparoscopic Bariatric Surgery: A Double-Blinded Randomized Clinical Trial
by: Shervin Shahinpour, et al.
Published: (2023-05-01)

ANESTHETIC CONCERNS IN PAEDS CARDIAC CATHETERIZATION AT ARMED FORCES INSTITUTE OF CARDIOLOGY / NATIONAL INSTITUTE OF HEART DISEASES
by: Dr Amna, et al.
Published: (2020-12-01)

Efficacy of aprepitant for prevention of postoperative nausea and vomiting. Systematic review and meta-analysis of randomized clinical trials
by: Berrío Valencia, Marta Inés, et al.
Published: (2014-10-01)

Hemodynamic Consequence of Interventional Cardiac Catheterization in the Early Postoperative Period after Congenital Heart Surgery
by: Daniel E. Eason, et al.
Published: (2023-06-01)

Postoperative Nausea and Vomiting in Cancer Surgery: Present Views on the Solution of the Old Problem
by: D. S. Baskakov, et al.
Published: (2013-04-01)

Assessment of Dog Owner Concern Regarding Peri-operative Nausea and Vomiting and Willingness to Pay for Anti-emetic Treatment
by: Bonnie L. Hay Kraus, et al.
Published: (2019-08-01)

Congenital heart disease cardiac catheterization at Uganda Heart Institute, a 12-year retrospective study of immediate outcomes
by: Nestor Mbabazi, et al.
Published: (2024-08-01)

Spectrum of Grown up Congenital Heart (GUCH) at Armed Forces Institute of Cardiology/ National Institute of Heart Diease: 10 years Experience
by: Hajira Akbar, et al.
Published: (2022-11-01)

Low-dose naloxone for prophylaxis of sufentanil-induced choking and postoperative nausea and vomiting
by: Yiling Qian, et al.
Published: (2022-11-01)

The Comparison of Pulse Oximetry and Cardiac Catheterization in Managing the Treatment of Children with Congenital Heart Disease
by: R Abbasi, et al.
Published: (2015-03-01)

To Study the Efficacy of Granisetron and Granisetron Plus Dexamethasone in Preventing the Incidence of Nausea and Vomiting in Patients Undergoing Laparoscopic Surgeries
by: Swarnamba U Nagappa, et al.
Published: (2022-11-01)

Risk Factors Associated with Chemotherapy-Induced Nausea and Vomiting Among Women with Breast Cancer Receiving Highly Emetogenic Chemotherapy: Individual Patient-Based Analysis of Three Prospective Antiemetic Trials
by: Yeo W, et al.
Published: (2024-04-01)

Comparison of granisetron and palonosetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic surgery: a prospective randomised study.
by: Priyanka Singh, et al.
Published: (2024-09-01)